Protagonist Therapeutics Inc (PTGX): Gewinn- und Verlustrechnung
Kennzahl in 1000 USD | TTM 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 281.992 | 46.016 | 434.433 | 60.000 | 26.581 | 27.357 | 28.628 | 231 | 30.925 | 20.063 |
Herstellungskosten | 783 | 1.225 | 2.963 | 3.312 | 1.032 | 2.775 | - | - | - | 57.554 |
Bruttoergebnis | 281.585 | 44.791 | 434.433 | 60.000 | 26.581 | 27.357 | 28.628 | 231 | 30.925 | 20.063 |
▸ Brutto-Marge | 99,86% | 97,34% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
Betriebliche Aufwendungen | 223.243 | 202.918 | 181.590 | 153.652 | 157.954 | 153.202 | 93.144 | 80.752 | 73.194 | 57.960 |
Operativer Gewinn/Verlust | 58.342 | -158.127 | 252.843 | -93.652 | -131.373 | -125.845 | -64.516 | -80.521 | -42.269 | -37.897 |
▸ Operative Marge | 20,69% | -343,63% | 58,2% | -156,09% | -494,24% | -460,01% | -225,36% | -34.857,58% | -136,68% | -188,89% |
Zinsen (Netto) | 26.115 | 28.789 | 26.315 | 12.907 | 691 | -2.038 | 302 | 2.644 | 2.546 | 940 |
▸ Zinsausgaben | - | - | - | - | 3.369 | 2.481 | 598 | 169 | - | - |
▸ Zinseinnahmen | 26.115 | 28.789 | 26.315 | 12.907 | 4.060 | 443 | 900 | 2.813 | 2.546 | 940 |
Andere Ausgaben | 119 | -27 | -250 | -1.790 | -3.289 | -2.332 | 631 | 1 | - | - |
Gewinn vor Steuern | 84.338 | -129.311 | 279.408 | -78.955 | -127.393 | -125.551 | -64.845 | -77.878 | -39.723 | -36.957 |
Steueraufwand | 1.429 | 838 | 4.220 | -14.898 | -3.980 | -2.924 | 1.305 | -691 | -799 | -406 |
Minderheitenanteil | - | - | - | 14.898 | - | 2.924 | - | - | - | 406 |
Nettogewinn/-verlust | 82.909 | -130.149 | 275.188 | -78.955 | -123.413 | -125.551 | -66.150 | -77.187 | -38.924 | -36.957 |
▸ Netto-Marge | 29,4% | -282,83% | 63,34% | -131,59% | -464,29% | -458,94% | -231,07% | -33.414,29% | -125,87% | -184,2% |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.